Emmessar Biotech

Market Cap: Micro Cap
Industry: Commodity Chemicals
ISIN: INE634B01016
NSEID:
BSEID: 524768

INR

29.20

0.15 (0.52%)

BSENSE

Dec 05

BSE+NSE Vol: 3.96 k

{
  "main_header": {
    "sid": 879996,
    "name": "Emmessar Biotech",
    "stock_name": "Emmessar Biotech",
    "full_name": "Emmessar Biotech & Nutrition Ltd",
    "name_url": "stocks-analysis/emmessar-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.20",
    "chg": 0.15,
    "chgp": "0.52%",
    "dir": 1,
    "prev_price": "29.05",
    "mcapval": "15.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524768,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE634B01016",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "3.96 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emmessar-biotech-879996-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3745006",
        "imagepath": "",
        "date": "2025-12-04 00:51:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Underperformance Against Benchmarks</strong></p>\n<p>Emmessar Biotech's recent price action is part of a sustained period of weakness relative to the broader market. Over the past week, the stock has declined by 10.03%, a stark contrast to the Sensex's marginal fall of 0.59%. This underperformance extends over longer horizons, with the stock down 6.90% in the last month while the Sensex gained 1.34%. Year-to-date figures reveal a more pronounced divergence, as Emmessar Biotech has lost 37.62% compared to the Sensex's 8.92% gain. Over one year, the stock's decline of 39.30% contrasts sharply with the Sensex's 5.27% increase, underscoring the company's struggles amid a generally rising market.</p>\n<p><strong>Short-Term Price Dynamics and Trading Patterns</strong></p>\n<p>On the day in..."
      },
      {
        "title": "How has been the historical performance of Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-emmessar-biotech-3695470",
        "imagepath": "",
        "date": "2025-11-13 00:26:09",
        "description": "Answer:\nThe historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nEmmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3693601",
        "imagepath": "",
        "date": "2025-11-12 22:58:18",
        "description": "As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock.\n\nIn the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'..."
      },
      {
        "title": "When is the next results date for Emmessar Biotech?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-emmessar-biotech-3681227",
        "imagepath": "",
        "date": "2025-11-07 23:20:08",
        "description": "Emmessar Biotech will declare its results on 12 November 2025...."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3659915",
        "imagepath": "",
        "date": "2025-10-30 22:54:31",
        "description": "As of 30-Oct, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 29.56, which represents a decrease of Rs 1.44 or 4.65%. The stock has underperformed its sector by 4.23% today, reaching an intraday low of Rs 29.46. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also significantly decreased, falling by 58.12% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has declined by 8.77%, and year-to-date, it has fallen by 36.16%, contrasting sharply with the Sensex, which has gained 8.02% during the same period.\n\nIn the broader market context, Emmessar Biotech's performance has been notably weaker than the benchmark index, particularly in the short term, where it has underperformed by a significant margin. W..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3611247",
        "imagepath": "",
        "date": "2025-10-10 22:42:32",
        "description": "As of 10-Oct, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.50, reflecting a decrease of 0.38, or 1.19%. The stock has been underperforming, having fallen for the last two days with a total decline of 1.22%. In the past week, it has experienced a significant drop of 5.97%, while over the last month, it has shown a positive return of 14.55%. Despite these gains in the longer term, the stock is down 31.97% year-to-date and 29.83% over the past year. Notably, the stock's delivery volume has increased significantly, indicating rising investor participation, although it is currently underperforming its sector by 1.58%. There is no information available regarding positive or negative factors impacting the stock.\n\nBroader Market Context: The stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.59% over the past week. While Emmessar Biotech has shown some re..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3580635",
        "imagepath": "",
        "date": "2025-09-29 22:46:26",
        "description": "As of 29-Sep, Emmessar Biotech & Nutrition Ltd's stock is currently priced at Rs 32.20, reflecting a decline of Rs 1.75 or 5.15%. The stock has been underperforming, having fallen for three consecutive days, resulting in a total decline of 9.07% during this period. It opened with a loss of 2% today and reached an intraday low of Rs 32.01, indicating significant selling pressure. Additionally, the stock's delivery volume has drastically decreased by 92.39% compared to its 5-day average, suggesting a lack of investor interest. Over the past week, the stock has dropped by 9.96%, while its year-to-date performance shows a decline of 30.45%, indicating a challenging environment for the company.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.18% over the past week, Emmessar Biotech's performance has been notably worse. The stock's recent decline contrasts sharply with its..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3567643",
        "imagepath": "",
        "date": "2025-09-24 22:44:52",
        "description": "As of 24-Sep, Emmessar Biotech & Nutrition Ltd's stock price is currently at 35.49, reflecting an increase of 0.32 or 0.91%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this positive movement today, the stock has underperformed in the short term, with a 1-week return of -8.72%. However, it has performed well over the past month, with a return of +22.85%. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but below its 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume falling by 85.84% compared to the 5-day average, indicating reduced trading interest.\n\nBroader market context shows that while Emmessar Biotech has outperformed its sector by 1.4% today, its recent performance over the year has been negative, with a decline of -11.25%, compared to a slig..."
      },
      {
        "title": "Why is Emmessar Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-emmessar-biotech-fallingrising-3561606",
        "imagepath": "",
        "date": "2025-09-23 22:53:52",
        "description": "As of 23-Sep, Emmessar Biotech & Nutrition Ltd is currently priced at 35.30, reflecting a decline of 0.46, or 1.29%. The stock has been underperforming, having lost 10.41% over the last three days, and it is noted that it has underperformed its sector by 0.73% today. Despite trading above its moving averages across various time frames, the stock has seen a significant drop in investor participation, with delivery volume plummeting by 90.77% compared to the five-day average. Year-to-date, the stock is down 23.76%, contrasting with a 5.07% increase in the benchmark index, indicating a challenging performance relative to the market.\n\nBroader Market Context: In the short term, Emmessar Biotech's performance has been relatively strong, with a 1-week return of 8.95%, while the Sensex has slightly declined by 0.34%. However, over the longer term, the stock's year-to-date decline of 23.76% starkly contrasts with th..."
      }
    ],
    "total": 57,
    "sid": "879996",
    "stock_news_url": "https://www.marketsmojo.com/news/emmessar-biotech-nutrition-879996"
  },
  "announcements": [
    {
      "caption": "Newspaper Add",
      "datetime": "13-Nov-2025",
      "details": "Please refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended Sept 30 2025",
      "datetime": "12-Nov-2025",
      "details": "Please refer attachment",
      "source": "BSE"
    },
    {
      "caption": "Results For Quarter Ended September 30 2025",
      "datetime": "12-Nov-2025",
      "details": "Please refer attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Emmessar Biotech falling/rising?

2025-12-04 00:51:51

Persistent Underperformance Against Benchmarks

Emmessar Biotech's recent price action is part of a sustained period of weakness relative to the broader market. Over the past week, the stock has declined by 10.03%, a stark contrast to the Sensex's marginal fall of 0.59%. This underperformance extends over longer horizons, with the stock down 6.90% in the last month while the Sensex gained 1.34%. Year-to-date figures reveal a more pronounced divergence, as Emmessar Biotech has lost 37.62% compared to the Sensex's 8.92% gain. Over one year, the stock's decline of 39.30% contrasts sharply with the Sensex's 5.27% increase, underscoring the company's struggles amid a generally rising market.

Short-Term Price Dynamics and Trading Patterns

On the day in...

How has been the historical performance of Emmessar Biotech?

2025-11-13 00:26:09

Answer: The historical performance of Emmessar Biotech shows significant fluctuations in its financial metrics over the years. Breakdown: Emmessar Biotech's net sales have varied considerably, peaking at 6.99 Cr in Mar'21 before declining to 0.61 Cr in Mar'25. The total operating income followed a similar trend, with a high of 6.99 Cr in Mar'21 and a drop to 0.61 Cr in Mar'25. The company's total expenditure, excluding depreciation, has also seen fluctuations, reaching a high of 6.14 Cr in Mar'21 and decreasing to 1.56 Cr in Mar'25. Operating profit (PBDIT) has been negative in recent years, with a loss of 0.95 Cr in Mar'25, contrasting with a profit of 0.85 Cr in Mar'21. Profit after tax has decreased from 1.45 Cr in Mar'21 to 0.32 Cr in Mar'25. The company's total assets have increased from 5.19 Cr in Mar'20 to 9.22 Cr in Mar'25, while total liabilities have also risen from 5.19 Cr to 9.22 Cr in the same...

Why is Emmessar Biotech falling/rising?

2025-11-12 22:58:18

As of 12-Nov, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.05, reflecting a slight increase of 0.05, or 0.16%. The stock has been gaining for the last two days, with a total return of 3.53% during this period. However, it has underperformed its sector by 0.92% today. In terms of longer-term performance, the stock has experienced a decline of 1.43% over the past month and a significant drop of 32.94% year-to-date. Despite these challenges, there has been a notable increase in investor participation, with delivery volume rising by 405.63% compared to the 5-day average, indicating growing interest in the stock. In the broader market context, the Sensex has outperformed Emmessar Biotech, returning 1.21% over the past week and 2.38% over the past month, while the stock has seen negative returns in both timeframes. Year-to-date, the Sensex has gained 8.10%, contrasting sharply with Emmessar'...

When is the next results date for Emmessar Biotech?

2025-11-07 23:20:08

Emmessar Biotech will declare its results on 12 November 2025....

Why is Emmessar Biotech falling/rising?

2025-10-30 22:54:31

As of 30-Oct, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 29.56, which represents a decrease of Rs 1.44 or 4.65%. The stock has underperformed its sector by 4.23% today, reaching an intraday low of Rs 29.46. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also significantly decreased, falling by 58.12% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has declined by 8.77%, and year-to-date, it has fallen by 36.16%, contrasting sharply with the Sensex, which has gained 8.02% during the same period. In the broader market context, Emmessar Biotech's performance has been notably weaker than the benchmark index, particularly in the short term, where it has underperformed by a significant margin. W...

Why is Emmessar Biotech falling/rising?

2025-10-10 22:42:32

As of 10-Oct, Emmessar Biotech & Nutrition Ltd's stock price is currently at 31.50, reflecting a decrease of 0.38, or 1.19%. The stock has been underperforming, having fallen for the last two days with a total decline of 1.22%. In the past week, it has experienced a significant drop of 5.97%, while over the last month, it has shown a positive return of 14.55%. Despite these gains in the longer term, the stock is down 31.97% year-to-date and 29.83% over the past year. Notably, the stock's delivery volume has increased significantly, indicating rising investor participation, although it is currently underperforming its sector by 1.58%. There is no information available regarding positive or negative factors impacting the stock. Broader Market Context: The stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.59% over the past week. While Emmessar Biotech has shown some re...

Why is Emmessar Biotech falling/rising?

2025-09-29 22:46:26

As of 29-Sep, Emmessar Biotech & Nutrition Ltd's stock is currently priced at Rs 32.20, reflecting a decline of Rs 1.75 or 5.15%. The stock has been underperforming, having fallen for three consecutive days, resulting in a total decline of 9.07% during this period. It opened with a loss of 2% today and reached an intraday low of Rs 32.01, indicating significant selling pressure. Additionally, the stock's delivery volume has drastically decreased by 92.39% compared to its 5-day average, suggesting a lack of investor interest. Over the past week, the stock has dropped by 9.96%, while its year-to-date performance shows a decline of 30.45%, indicating a challenging environment for the company. Broader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.18% over the past week, Emmessar Biotech's performance has been notably worse. The stock's recent decline contrasts sharply with its...

Why is Emmessar Biotech falling/rising?

2025-09-24 22:44:52

As of 24-Sep, Emmessar Biotech & Nutrition Ltd's stock price is currently at 35.49, reflecting an increase of 0.32 or 0.91%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this positive movement today, the stock has underperformed in the short term, with a 1-week return of -8.72%. However, it has performed well over the past month, with a return of +22.85%. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but below its 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume falling by 85.84% compared to the 5-day average, indicating reduced trading interest. Broader market context shows that while Emmessar Biotech has outperformed its sector by 1.4% today, its recent performance over the year has been negative, with a decline of -11.25%, compared to a slig...

Why is Emmessar Biotech falling/rising?

2025-09-23 22:53:52

As of 23-Sep, Emmessar Biotech & Nutrition Ltd is currently priced at 35.30, reflecting a decline of 0.46, or 1.29%. The stock has been underperforming, having lost 10.41% over the last three days, and it is noted that it has underperformed its sector by 0.73% today. Despite trading above its moving averages across various time frames, the stock has seen a significant drop in investor participation, with delivery volume plummeting by 90.77% compared to the five-day average. Year-to-date, the stock is down 23.76%, contrasting with a 5.07% increase in the benchmark index, indicating a challenging performance relative to the market. Broader Market Context: In the short term, Emmessar Biotech's performance has been relatively strong, with a 1-week return of 8.95%, while the Sensex has slightly declined by 0.34%. However, over the longer term, the stock's year-to-date decline of 23.76% starkly contrasts with th...

View All News